• Dissecting Drug Responses: In Vitro Metrics in Cancer Resear

  2026-05-25

  Schwartz's dissertation advances the evaluation of anti-cancer agents by distinguishing between relative viability and fractional viability in in vitro assays, revealing that most drugs impact both proliferation and cell death, but with distinct timing and proportions. These insights improve the precision and interpretability of preclinical drug response data, guiding the development and assessment of agents such as p53 pathway modulators.

• IGFBP2–THBS1 Axis in GH-Induced Bone Growth for Short Statur

  2026-05-24

  This study reveals a novel mechanism by which recombinant human growth hormone (GH) promotes bone growth in children with idiopathic short stature (ISS) via the IGFBP2–THBS1–IGF-1 pathway. By detailing the central role of IGFBP2-mediated inhibition of THBS1 in enhancing chondrocyte proliferation and differentiation, the findings provide new targets for optimizing GH therapy and experimental bone growth models.

• Inflammation in Ischemic Stroke: Biomarkers and Therapies

  2026-05-23

  This comprehensive review synthesizes the complex relationship between neuroinflammation and ischemic stroke progression. By integrating mechanistic insights with clinical biomarkers and emerging treatments, it offers researchers a unified framework for understanding and addressing inflammation-driven brain injury.

• ETS1 Modulates Mitophagy via SENP2/HSPA8/FUNDC1 in BPD Model

  2026-05-22

  The referenced study elucidates how ETS1 acts as a transcriptional regulator that mitigates bronchopulmonary dysplasia (BPD) by inhibiting mitochondrial damage-induced autophagy through the SENP2/HSPA8/FUNDC1 axis. This mechanistic insight advances understanding of mitophagy control in lung development and highlights new avenues for targeted autophagy pathway modulation.

• CCG-1423: Precision RhoA Inhibitor Workflows for Cancer & Vi

  2026-05-22

  CCG-1423 empowers researchers to dissect the RhoA/ROCK signaling axis with unmatched selectivity, enabling breakthroughs in cancer and viral pathogenesis studies. Discover protocol enhancements, troubleshooting strategies, and practical insights to maximize the utility of this APExBIO small-molecule inhibitor.

• EGTA in Neurocardiac Research: Mechanistic Precision for Cal

  2026-05-21

  Explore how EGTA (egtaszic acid) enables advanced neurocardiac research through selective calcium chelation. This article uncovers unique mechanistic insights and protocol strategies, offering a deeper perspective on calcium signaling pathway modulation.

• Ceapin-A7: Strategic ATF6α Pathway Inhibition in ER Stress R

  2026-05-21

  Ceapin-A7, a selective ER stress blocker from APExBIO, empowers translational researchers to dissect and modulate the ATF6α signaling axis within the unfolded protein response. By leveraging the latest mechanistic findings in inflammation and cell death, this article integrates experimental rationale, protocol guidance, and strategic insights for advancing endoplasmic reticulum stress research, with a focus on intervertebral disc degeneration and beyond.

• Chrysanthemum indicum L. Extract Induces Apoptosis in Glioma

  2026-05-20

  This study integrates network pharmacology, molecular docking, and both in vivo and in vitro experiments to uncover how Chrysanthemum indicum L. extract (CIE) exerts anti-glioma effects. The research identifies key molecular targets and demonstrates that CIE inhibits glioma cell proliferation and migration while promoting apoptosis, providing a mechanistic basis for botanical therapeutics in glioma research.

• Hoechst 33342/PI Double Staining Kit: Optimizing Apoptosis D

  2026-05-20

  The Hoechst 33342/PI Double Staining Kit from APExBIO enables precise, rapid discrimination of viable, apoptotic, and necrotic cells in research workflows. This article details advanced protocols, troubleshooting, and direct applications in therapeutic efficacy studies, empowering researchers to maximize data confidence in cell death assays.

• Tivozanib (AV-951): Applied Workflows in VEGFR Inhibition Re

  2026-05-19

  Tivozanib (AV-951) enables precise, reproducible VEGFR inhibition with superior selectivity in anti-angiogenic and renal cell carcinoma models. This guide details practical workflows, troubleshooting strategies, and advanced assay design rooted in the latest in vitro evaluation frameworks.

• Brassinolide (24-Epibrassinolide): Precision in Plant and Bi

  2026-05-19

  Brassinolide stands out as both a powerful plant growth regulator and a versatile apoptosis inducer in cancer and diabetes models. This article delivers actionable workflows, troubleshooting guidance, and a practical translation of the latest reference study—empowering researchers to achieve reproducibility across plant and biomedical domains.

• Applied Cell Proliferation Assays with Cell Counting Kit-8 (

  2026-05-18

  The Cell Counting Kit-8 (CCK-8) streamlines cell proliferation, viability, and cytotoxicity assays with high sensitivity and workflow simplicity. This article details stepwise protocol enhancements, advanced applications in ischemia and drug delivery research, and actionable troubleshooting to maximize reliability in diverse biomedical settings.

• CD24-Driven Ectosome Formation in B Cells: Mechanisms and Pa

  2026-05-18

  This study elucidates how CD24 regulates the formation of bioactive ectosomes in B lymphocytes via a PI3K/mTORC2/ROCK/actin pathway, with acid sphingomyelinase playing a pivotal upstream role. The work reveals a selective mechanism for ectosome—but not exosome—release, advancing our understanding of extracellular vesicle dynamics in B cell biology.

• DGLA-Induced Ferroptosis via ACSL4 in AML: Lipid Metabolic R

  2026-05-17

  This study demonstrates that exogenous dihomo-γ-linolenic acid (DGLA) triggers ferroptosis in acute myeloid leukemia (AML) cells through ACSL4-mediated lipid metabolic reprogramming. The findings suggest new therapeutic avenues for overcoming chemotherapy resistance in AML by targeting lipid metabolism and ferroptotic pathways.

• α-KG Restores HPDLSC Function via LKB1-AMPK Activation in Pe

  2026-05-16

  This study uncovers how α-ketoglutarate (α-KG) alleviates mitochondrial dysfunction and cellular senescence in human periodontal ligament stem cells (HPDLSCs) under periodontitis-associated inflammation by activating the LKB1-AMPK pathway. The findings offer mechanistic insight into stem cell-based regeneration strategies for periodontal disease.

451 records 17/31 page Previous Next First page 上5页 1617181920 下5页 Last page